Pasithea Therapeutics Corp. (KTTA) vs Sintx Technologies, Inc. (SINT)
A side-by-side comparison of Pasithea Therapeutics Corp. and Sintx Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KTTA
Pasithea Therapeutics Corp.
$0.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SINT
Sintx Technologies, Inc.
$2.18HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT
Total return — KTTA vs SINT
growth of $100 · dividends reinvested · last 4yKTTA -98.8% (-67.1%/yr)SINT -100.0% (-87.9%/yr)KTTA compounded faster over this window
Log scale — wide-divergence pair
KTTA SINT
KTTA vs SINT: by the numbers
- •KTTA is the larger company ($15M vs $14M market cap).
- •Both run net losses; KTTA's is the smaller (0.00% vs -1303.40% net margin).
Metrics side by side
Valuation
| Metric | KTTA | SINT |
|---|---|---|
| P/S ratio | N/A | 10.04 |
| P/B ratio | 0.30 | 2.87 |
Profitability
| Metric | KTTA | SINT |
|---|---|---|
| Gross margin | 0.00% | -19.74% |
| Operating margin | 0.00% | -1053.14% |
| Net margin | 0.00% | -1303.40% |
| ROE | -42.72% | -372.67% |
| ROIC | -48.04% | -157.90% |
Growth (annualized)
| Metric | KTTA | SINT |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 29.18% |
| Total return CAGR (5Y) | -61.48% | N/A |
Go deeper
Dig into the metrics
Pasithea Therapeutics ROESintx Technologies ROEPasithea Therapeutics operating marginSintx Technologies operating marginPasithea Therapeutics revenue growthSintx Technologies revenue growthPasithea Therapeutics free cash flowSintx Technologies free cash flow
Pasithea Therapeutics & Sintx Technologies appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.